H Satti

Summary

Affiliation: Partners In Health
Country: USA

Publications

  1. pmc Drug-resistant tuberculosis treatment complicated by antiretroviral resistance in HIV coinfected patients: a report of six cases in Lesotho
    Hind Satti
    Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA
    Am J Trop Med Hyg 89:174-7. 2013
  2. pmc Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho
    Hind Satti
    Partners In Health, Maseru, Lesotho
    PLoS ONE 7:e46943. 2012
  3. doi request reprint High risk of drug-resistant tuberculosis when first-line therapy fails in a high HIV prevalence setting
    H Satti
    Partners In Health, Maseru, Lesotho
    Int J Tuberc Lung Dis 17:100-6. 2013
  4. pmc Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence
    Hind Satti
    Partners In Health, Maseru, Lesotho
    PLoS ONE 7:e37114. 2012
  5. pmc Comprehensive approach to improving maternal health and achieving MDG 5: report from the mountains of Lesotho
    Hind Satti
    Partners in Health Lesotho, Maseru, Lesotho
    PLoS ONE 7:e42700. 2012
  6. doi request reprint High rate of hypothyroidism among patients treated for multidrug-resistant tuberculosis in Lesotho
    H Satti
    Partners in Health Lesotho, Maseru, Lesotho
    Int J Tuberc Lung Dis 16:468-72. 2012

Detail Information

Publications6

  1. pmc Drug-resistant tuberculosis treatment complicated by antiretroviral resistance in HIV coinfected patients: a report of six cases in Lesotho
    Hind Satti
    Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA
    Am J Trop Med Hyg 89:174-7. 2013
    ..Coinfected patients undergoing DR-TB treatment may require closer monitoring of their response to ART, including routine viral load testing, to ensure that they receive an effective ART regimen concurrent with DR-TB treatment...
  2. pmc Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho
    Hind Satti
    Partners In Health, Maseru, Lesotho
    PLoS ONE 7:e46943. 2012
    ..We report final outcomes of comprehensive, integrated MDR-TB and HIV treatment in Lesotho and examine factors associated with death or treatment failure...
  3. doi request reprint High risk of drug-resistant tuberculosis when first-line therapy fails in a high HIV prevalence setting
    H Satti
    Partners In Health, Maseru, Lesotho
    Int J Tuberc Lung Dis 17:100-6. 2013
    ..Lesotho national multidrug-resistant tuberculosis (MDR-TB) program...
  4. pmc Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence
    Hind Satti
    Partners In Health, Maseru, Lesotho
    PLoS ONE 7:e37114. 2012
    ..In Lesotho, where the adult HIV seroprevalence is estimated to be 24%, we sought to measure outcomes and adverse events in a cohort of children treated for MDR-TB using a community-based treatment delivery model...
  5. pmc Comprehensive approach to improving maternal health and achieving MDG 5: report from the mountains of Lesotho
    Hind Satti
    Partners in Health Lesotho, Maseru, Lesotho
    PLoS ONE 7:e42700. 2012
    ....
  6. doi request reprint High rate of hypothyroidism among patients treated for multidrug-resistant tuberculosis in Lesotho
    H Satti
    Partners in Health Lesotho, Maseru, Lesotho
    Int J Tuberc Lung Dis 16:468-72. 2012
    ..Hypothyroidism is a known side effect of treatment for multidrug-resistant tuberculosis (MDR-TB), but it is considered to be rare. Hypothyroidism has vague and non-specific symptoms, and can be easily missed by clinicians...